Kurt Meppelink, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 3912 32nd Ave, Hudsonville, MI 49426 Phone: 616-252-8700 |
Kelly B Huggett, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3152 Port Sheldon St, Suite C, Hudsonville, MI 49426 Phone: 616-669-9238 Fax: 616-669-8296 |
Caitlin Mlynarek, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3912 32nd Ave, Hudsonville, MI 49426 Phone: 616-252-8700 Fax: 616-252-8750 |
Dr. Kimberly Bain Mitcham, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 3152 Port Sheldon St Ste C, Hudsonville, MI 49426 Phone: 616-669-9238 |
Joash Ajay Raj, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3152 Port Sheldon St, Suite C, Hudsonville, MI 49426 Phone: 616-669-9238 |
Ruel Lirio, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3152 Port Sheldon St, Hudsonville, MI 49426 Phone: 616-669-9238 Fax: 616-669-8296 |
Dr. Antje Southwick Dew, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3152 Port Sheldon St, Suite C, Hudsonville, MI 49426 Phone: 616-669-9238 Fax: 616-669-8296 |
News Archive
Today, Lung Cancer Alliance (LCA) praised the growing coalition of national organizations joining LCA in its "call to action" to devise a better public health strategy to address the nation's most lethal cancer.
According to a latest report from the think tank the Centre for Policy Studies (CPS), drug addiction costs £3.6bn a year for both treating problem drug users and keeping them on benefits. The study by has criticised government plans to change the way authorities tackle drug addiction. It claims the plans for payment-by-results schemes are "doomed to failure, not least because they are being run by the very organizations responsible for the current failure of policy".
Boston Micromachines Corporation, a leading provider of MEMS-based deformable mirror (DM) products for adaptive optics systems, announced today that its Multi-DM deformable mirror is being used at the University of Rochester Center for Vision Science's Yoon Lab in its research to improve vision performance.
TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and related diseases, announced today that new data on TRC105 and TRC102 will be presented at the 22nd Annual EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.
The majority of disease-causing bacteria in the body are rendered harmless by the protective effects of the immune system. Those that manage to escape the immune system can be killed by antibiotics, but bacteria are becoming more and more resistant to more and more antibiotics.
› Verified 1 days ago